May 2016 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2014/15 Invitation to Tender, dated 6 November 2014, and the 2015/16 Invitation to Tender, dated 6 November 2015.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode(external link)) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2014/15 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2018

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Tobramycin Inj 40 mg per ml, 2 ml vial, 5 vials $38.00 $15.00 Tobramycin Mylan(Mylan) 1 December 2016 1 February 2017 1 May 2017 DBL Tobramycin(Hospira)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name

Presentation;
Pack size and type

Current price New price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Midazolam Inj 1 mg per ml, 5 ml ampoule, 10 ampoules $10.75 $4.30 Midazolam-Claris(AFT) 5% 1 October 2016 1 December 2016 Hypnovel(Roche)Pfizer(Pfizer)
Midazolam Inj 5 mg per ml, 3 ml ampoule, 5 ampoules $11.90 $2.50 Midazolam-Claris(AFT) 5% 1 October 2016 1 December 2016 Hypnovel(Roche)Pfizer(Pfizer)
Tobramycin Inj 40 mg per ml, 2 ml vial, 5 vials $38.00 $15.00 Tobramycin Mylan(Mylan) 1% 1 December 2016 1 February 2017 DBL Tobramycin(Hospira)

2015/16 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2019

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

CORRECTION to May 2016 tender notification: in bold and strikethrough

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date
Amisulpride* Oral liq 100 mg per ml, 60 ml $52.50 $65.53 Solian(Sanofi) 1 August 2016 1 November 2016
Clotrimazole Vaginal crm 1% with applicators, 35 g OP $1.45 $1.60 Clomazol(Multichem) 1 September 2016 1 December 2016
Clotrimazole Vaginal crm 12% with applicators, 20 g OP $2.20 $2.10 Clomazol(Multichem) 1 September 2016 1 December 2016
Ipratropium bromide Nebuliser soln, 250 mcg per ml, 1 ml ampoule, 20 ampoules $3.26 $3.35 Univent(Rex Medical) 1 October 2016 1 January 2017
Ipratropium bromide Nebuliser soln, 250 mcg per ml, 2 ml ampoule, 20 ampoules $3.37 $3.52 Univent(Rex Medical) 1 October 2016 1 January 2017
Omeprazole Inj 40 mg ampoule with diluent, 5 ampoules $33.65 $33.98 Dr Reddy’s Omeprazole(Dr Reddy’s) 1 July 2016 1 October 2016
Oxybutynin Oral liq 5 mg per 5 ml, 473 ml $56.45 $60.40 Apo-Oxybutynin(Apotex) 1 July 2016 1 October 2016
Oxybutynin Tab 5 mg, 500 tablets $11.20 $8.85 Apo-Oxybutynin(Apotex) 1 July 2016 1 October 2016
Ropinirole hydrochloride Tab 0.25 mg, 100 tablets $2.36 $2.78 Apo-Ropinirole(Apotex) 1 July 2016 1 October 2016
Ropinirole hydrochloride Tab 1 mg, 100 tablets $5.32 $5.00 Apo-Ropinirole(Apotex) 1 July 2016 1 October 2016
Ropinirole hydrochloride Tab 2 mg, 100 tablets $7.72 $7.72 Apo-Ropinirole(Apotex) 1 July 2016 1 October 2016
Ropinirole hydrochloride Tab 5 mg, 100 tablets $14.48 $16.51 Apo-Ropinirole(Apotex) 1 July 2016 1 October 2016
Sodium chloride Inj 0.9%, bag, 500 ml $3.06 $1.23 Baxter(Baxter) 1 July 2016 1 October 2016
Sodium chloride Inj 0.9%, bag, 1000 ml $4.06 $1.26 Baxter(Baxter) 1 July 2016 1 October 2016
Terazosin Tab 1 mg, 28 tablets $0.50 $0.59 Actavis(Actavis) 1 July 2016 1 October 2016
*Amisulpride will be supplied by Sanofi at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2015/16 Invitation To Tender.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Ceftriaxone Inj 500 mg vial, 1 vial $1.50 $1.20 DEVA(Deva Holdings) 1 September 2016 1 November 2016 1 February 2017 Ceftriaxone-AFT(AFT)
Ceftriaxone Inj 1 g vial. 1 vial $5.22 per 5 vials $0.84 per vial DEVA(Deva Holdings) 1 September 2016 1 November 2016 1 February 2017 Ceftriaxone-AFT(AFT)
Paroxetine1 Tab 20 mg, 90 tablets $4.32 $4.02 Apo-Paroxetine(Apotex) 1 February 2017 1 April 2017 1 July 2017 Loxamine(Mylan)
Terazosin Tab 2 mg, 500 tablets $0.45 per 28 tablets $7.50 per 500 tablets Apo-Terazosin(Apotex) 1 December 2016 1 February 2017 1 May 2017 Arrow(Actavis)
Terazosin Tab 5 mg, 500 tablets $0.57 $0.68 per 28 tablets $10.90 per 500 tablets Apo-Terazosin(Apotex) 1 December 2016 1 February 2017 1 May 2017 Arrow(Actavis)

The decisions were as follows:1Brand switch fee of $4.33 is payable for this product from 1 July 2017 until 1 October 2017.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

CORRECTION to May 2016 tender notification: in bold and strikethrough

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date
Amisulpride* Oral liq 100 mg per ml, 60 ml $52.50 $65.53 Solian(Sanofi) 1% 1 August 2016 1 October 2016
Clotrimazole Vaginal crm 1% with applicators, 35 g OP $1.45 $1.60 Clomazol(Multichem) 1% 1 September 2016 1 November 2016
Clotrimazole Vaginal crm 12% with applicators, 20 g OP $2.20 $2.10 Clomazol(Multichem) 1% 1 September 2016 1 November 2016
Ipratropium bromide Nebuliser soln, 250 mcg per ml, 1 ml ampoule, 20 ampoules $3.26 $3.35 Univent(Rex Medical) 1% 1 October 2016 1 December 2016
Ipratropium bromide Nebuliser soln, 250 mcg per ml, 2 ml ampoule, 20 ampoules $3.37 $3.52 Univent(Rex Medical) 1% 1 October 2016 1 December 2016
Omeprazole Inj 40 mg ampoule with diluent, 5 ampoules $28.65 
$33.65
$33.98 Dr Reddy’s Omeprazole(Dr Reddy’s) 1% 1 July 2016 1 September 2016
Oxybutynin Oral liq 5 mg per 5 ml, 473 ml $56.45 $60.40 Apo-Oxybutynin(Apotex) 1% 1 July 2016 1 September 2016
Oxybutynin Tab 5 mg, 500 tablets $11.20 $8.85 Apo-Oxybutynin(Apotex) 1% 1 July 2016 1 September 2016
Ropinirole hydrochloride Tab 0.25 mg, 100 tablets $2.36 $2.78 Apo-Ropinirole(Apotex) 1% 1 July 2016 1 September 2016
Ropinirole hydrochloride Tab 1 mg, 100 tablets $5.32 $5.00 Apo-Ropinirole(Apotex) 1% 1 July 2016 1 September 2016
Ropinirole hydrochloride Tab 2 mg, 100 tablets $7.72 $7.72 Apo-Ropinirole(Apotex) 1% 1 July 2016 1 September 2016
Ropinirole hydrochloride Tab 5 mg, 100 tablets $14.48 $16.51 Apo-Ropinirole(Apotex) 1% 1 July 2016 1 September 2016
Sodium chloride Inj 0.45%, bag, 500 ml, 18 bags $5.50 per bag $71.28 per 18 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
Sodium chloride Inj 0.9%, bag, 50 ml, 60 bags $3.01 per bag $109.80 per 60 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
Sodium chloride Inj 0.9%, bag, 100 ml, 48 bags $2.28 per bag $78.24 per 48 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
Sodium chloride Inj 0.9%, bag, 250 ml, 24 bags $3.60 per bag $44.64 per 24 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
Sodium chloride Inj 3%, bag, 1,000 ml, 12 bags $5.69 per bag $91.20 per 12 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
Sodium hyaluronate [hyaluronic acid] Inj 14 mg per ml, 0.55 ml syringe, 1 syringe $50.00 $50.00 Healon GV(Abbott) 1% 1 July 2016 1 September 2016
Sodium hyaluronate [hyaluronic acid] Inj 14 mg per ml, 0.85 ml syringe; 1 syringe $50.00 $50.00 Healon GV(Abbott) 1% 1 July 2016 1 September 2016
Sodium hyaluronate [hyaluronic acid] with chondroitin sulphate Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.5 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.55 ml syringe, 1 treatment pack $74.00 $74.00 DuoVisc(Alcon) 1% 1 July 2016 1 September 2016
Terazosin Tab 1 mg, 28 tablets $0.50 $0.59 Actavis(Actavis) 1% 1 July 2016 1 September 2016
Water for injection Inj, bag, 1,000 ml, 12 bags $2.75 per bag $19.08 per 12 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016
*Amisulpride will be supplied by Sanofi at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2015/16 Invitation To Tender.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Ceftriaxone Inj 500 mg vial, 1 vial $1.50 $1.20 DEVA(Deva Holdings) 1% 1 September 2016 1 November 2016 Ceftriaxone-AFT(AFT)
Ceftriaxone Inj 1 g vial, 1 vial $5.22 per 5 vials $0.84 per vial DEVA(Deva Holdings) 1% 1 September 2016 1 November 2016 Ceftriaxone-AFT(AFT)
Iloprost Inj 50 mcg in 0.5 ml ampoule, 5 ampoules $89.50 per ampoule $380.00 per 5 ampoules Ilomedin(Bayer) 1% 1 November 2016 1 January 2017 Arrow – Iloprost(Actavis)
Omeprazole Inj 40 mg vial, 5 vial $19.00 $13.00 Omezol IV(Mylan) 1% 1 November 2016 1 January 2017 Dr Reddy’s Omeprazole(Dr Reddy’s)
Ondansetron Inj 2 mg per ml, 2 ml ampoule, 5 ampoules $1.82 $1.50 Ondansetron-Claris(AFT) 1% 1 July 2016 1 September 2016 Ondanaccord(Actavis)
Ondansetron Inj 2 mg per ml, 4 ml ampoule, 5 ampoules $2.18 $2.20 Ondansetron Kabi(Fresenius Kabi) 1% 1 July 2016 1 September 2016 Ondanaccord(Actavis)
Paroxetine Tab 20 mg, 90 tablets $4.32 $4.02 Apo-Paroxetine(Apotex) 1% 1 February 2017 1 April 2017 Loxamine(Mylan)
Sodium chloride Inj 0.9%, bag, 500 ml, 18 bags $1.77 per bag (Baxter) $1.70 per bag (Fresenius Kabi) $22.14 per 18 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016 Freeflex(Fresenius Kabi)
Sodium chloride Inj 0.9%, bag, 1,000 ml, 12 bags $1.80 per bag (Baxter) $1.71 per bag (Fresenius Kabi) $15.12 per 12 bags Baxter(Baxter) 1% 1 July 2016 1 September 2016 Freeflex(Fresenius Kabi)
Sodium hyaluronate [hyaluronic acid] Inj 10 mg per ml, 0.85 ml syringe, 1 syringe $30.00 $28.50 Healon(Abbott) 1% 1 July 2016 1 September 2016 Provisc(Alcon)
Terazosin Tab 2 mg, 500 tablets $0.45 per 28 tablets $7.50 per 500 tablets Apo-Terazosin(Apotex) 1% 1 December 2016 1 February 2017 Arrow(Actavis)
Terazosin Tab 5 mg, 500 tablets $0.68 per 28 tablets $10.90 per 500 tablets Apo-Terazosin(Apotex) 1% 1 December 2016 1 February 2017 Arrow(Actavis)

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Pack Price

Hospital SupplyBrand (Supplier)

DVLimit

Listing date

Hospital Supply Status date

Sodium hyaluronate [hyaluronic acid]

Inj 23 mg per ml, 0.60 ml syringe, 1 syringe

$60.00

Healon 5(Abbott)

1%

1 July 2016

1 September 2016

Sodium hyaluronate [hyaluronic acid] with chondroitin sulphate

Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.75 ml syringe, 1 syringe

$67.00

Viscoat(Alcon)

1%

1 July 2016

1 September 2016

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2015/16 Invitation to Tender, dated 6 November 2015:

2015/16 Invitation to Tender

Chemical Name

Line Item

Chemical Name

Line Item

Acetazolamide

Inj 500 mg

Ibuprofen

Inj 5 mg per ml, 2 ml

Acetic acid with propyelene glycol

Ear drops 2.3% with propylene glycol 2.8%

Ibuprofen

Inj 10 mg per ml, 2 ml

Acetylcholine chloride

Inj 20 mg vial with diluent

Isosorbide mononitrate

Tab long-acting 60 mg

Albendazole

Tab 200 mg

Lidocaine [lignocaine] hydrochloride with adrenaline

Inj 1% with adrenaline 1:100,000, 5 ml

Albendazole

Tab 400 mg

Lidocaine [lignocaine] hydrochloride with adrenaline

Inj 1% with adrenaline 1:200,000, 20 ml

Alteplase

Inj 10 mg

Lidocaine [lignocaine] hydrochloride with adrenaline

Inj 2% with adrenaline 1:200,000, 20 ml

Alteplase

Inj 50 mg

Liposomal daunorubicin

Inj 50 mg

Alteplase

Inj 2 mg

Metoclopramide hydrochloride

Oral liq 5 mg per 5 ml

Artemether with lumefantrine

Tab 20 mg with lumefantrine 120 mg

Mexiletine

Cap 150 mg

Artesunate

Inj 60 mg

Mexiletine

Cap 250 mg

Aspirin

Suppos 300 mg

Nitazoxanide

Oral 100 mg per 5 ml

Betamethasone valerate with clioquinol

Crm 0.1% with clioquinol 3%

Nitrofurantoin

Oral liq

Betamethasone valerate with clioquinol

Oint 0.1% with clioquinol 3%

Nitrofurantoin

Tab modified-release 50 mg

Bupropion hydrochloride

Tab modified-release 150 mg

Pancuronium bromide

Inj 2 mg per ml, 2 ml

Ceftriaxone

Inj 2 g

Pentoxifylline [oxpentifylline]

Tab 400 mg

Chloroquine phosphate

Tab 250 mg

Praziquantel

Tab 600 mg

Chlortalidone [chlorthalidone]

Tab 25 mg

Prednisolone acetate

Eye drops 0.12%

Cholestyramine

Powder for oral liq 4 g

Primaquine phosphate

Tab 7.5 - 15 mg

Ciprofloxacin

Eye Drops 0.3%

Propranolol

Oral liq 4 mg per ml

Ciprofloxacin

Ear drops 0.3%

Sodium hyaluronate [hyaluronic acid] with chondroitin sulphate

Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.35 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.4 ml syringe

Clofazimine

Cap 50 mg

Sodium nitroprusside

Inj 50 mg

Clomiphene citrate

Tab 50 mg

Sulphadiazine

Tab 500 mg

Cyclizine lactate

Inj 50 mg per ml, 1 ml

Trimethoprim with sulphamethoxazole [Co-trimoxazole]

Tab trimethoprim 80 mg and sulphamethoxazole 400 mg

Cyclophosphamide

Tab 50 mg

Trimethoprim with sulphamethoxazole [Co-trimoxazole]

Inj 16 mg with sulphamethoxazole 80 mg per ml, 5 ml

Cycloserine

Cap 250 mg

Vecuronium

Inj 10 mg

Cytarabine

Inj 100 mg

Vecuronium

Inj 4 mg

Flucytosine

Cap 500 mg

Water for injection

Purified for injection, 500 ml bag

Framycetin sulphate

Ear/Eye drops 0.5%

   

Haloperidol decanoate

Inj 100 mg per ml, 1 ml

   

Haloperidol decanoate

Inj 50 mg per ml, 1 ml

   

Hyoscine (Scopolamine)

Patches, 1.5 mg

   

Hyoscine hydrobromide

Inj 400 mcg per ml, 1 ml

   

Hypromellose

Eye drops 0.5%

   

For products included in the 2014/15 and 2015/16 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.